Related Experiment Video

Updated: May 9, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.)

Jane Zhao1, Paul Lammers, Chris J Torrance

  • 1Mirna Therapeutics, Inc., Austin, Texas 78744, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|July 10, 2013
PubMed

Insights

MicroRNA-34 (miR-34) inhibits cancer cell growth independently of TP53 status by targeting HDAC1, leading to p21(CIP1/WAF1) upregulation. This suggests miR-34 as a potential cancer therapy for all patients.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • MicroRNA-34 (miR-34) is a tumor suppressor and a TP53 target, potentially activating TP53 in a feedback loop.
  • The TP53 feedback loop might limit miR-34's therapeutic use to patients with intact TP53.
  • Understanding miR-34's function relative to TP53 is crucial for cancer therapy development.

Purpose of the Study:

  • To investigate the functional relationship between TP53 and miR-34, including other TP53-regulated miRNAs like miR-215/192.
  • To determine if miR-34's tumor-suppressive functions are dependent on TP53.
  • To explore the therapeutic potential of miR-34 irrespective of TP53 mutational status.

Main Methods:

  • Utilized isogenic cancer cell lines differing only in TP53 status.
  • Assessed miR-34 and miR-215/192 function in TP53-positive and TP53-negative cells.
  • Identified direct targets of miR-34 and analyzed downstream effects on p21(CIP1/WAF1) and cell proliferation.

Main Results:

  • miR-34 inhibited cancer cell growth similarly in both TP53-positive and TP53-negative cells.
  • miR-215/192 function was dependent on TP53, unlike miR-34.
  • In TP53-negative cells, miR-34 upregulated p21(CIP1/WAF1) by repressing HDAC1, mimicking the miR-34 cellular phenotype.
  • Depletion of p21(CIP1/WAF1) specifically impaired miR-34's anti-proliferative effect.

Conclusions:

  • miR-34 controls a tumor suppressor pathway previously associated solely with TP53.
  • miR-34's function is independent of TP53, making it a promising therapeutic strategy for a broad range of cancer patients.
  • The miR-34/HDAC1/p21(CIP1/WAF1) axis represents a novel therapeutic target in cancer treatment.

More Related Videos

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells06:48

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells

Published on: June 16, 2022

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...